Anaes Vivas · Neuromuscular blockade & reversal
Mivacurium and butyrylcholinesterase
Viva on mivacurium pharmacology, its butyrylcholinesterase dependence, and the differences between the three benzylisoquinolines.
On this page
Study tools
Target exams
ANZCAFRCAABAEDAICFCAIFCA_SA
Prompt
A table of the three benzylisoquinoline relaxants with their elimination pathway, duration and histamine-release tendency.
Stimulus
A table of the three benzylisoquinoline relaxants with their elimination pathway, duration and histamine-release tendency.
References4ShowHide
- [1]Radkowski P, et al. Neuromuscular Blocking Agents in Anesthesia: A Narrative Review of Contemporary Challenges and Reversal Approaches. J Clin Med, 2026.PMID 42123245
- [3]Roy VC, et al. The Use of Cisatracurium in Cardiac Surgery. Turk J Anaesthesiol Reanim, 2025.PMID 40677119
- [4]Kempff-Andersen S, et al. Butyrylcholinesterase activity and prolonged duration of action of mivacurium in elderly patients (≥80 years): A secondary analysis of a clinical trial. Eur J Anaesthesiol, 2026.PMID 42298973
- [7]Snak de Souza CD, et al. Genotype-phenotype relationships in butyrylcholinesterase deficiency: a systematic review. Br J Anaesth, 2026.PMID 42120224